According to the CDC: Every three minutes and 11 seconds, someone dies of stroke. The medical device industry is answering the call in this country, developing new devices to help clear clots and speed patient recovery. Together with John Murray, Head of Global Strategic Marketing and Strategic Relationships at Johnson & Johnson MedTech Neurovascular, we'll talk with those pioneering neurosurgeons who are developing new procedures and setting higher expectations for new devices. We'll understand what drives them and learn how they view the future of this industry.
All content for Neuro Innovation Talks: J&J MedTech Neurovascular is the property of DeviceTalks Podcast Network and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
According to the CDC: Every three minutes and 11 seconds, someone dies of stroke. The medical device industry is answering the call in this country, developing new devices to help clear clots and speed patient recovery. Together with John Murray, Head of Global Strategic Marketing and Strategic Relationships at Johnson & Johnson MedTech Neurovascular, we'll talk with those pioneering neurosurgeons who are developing new procedures and setting higher expectations for new devices. We'll understand what drives them and learn how they view the future of this industry.
S1 E1 - J&J MedTech’s John Murray and Dr. Berenstein on the early evolution of neurovascular treatments
Neuro Innovation Talks: J&J MedTech Neurovascular
56 minutes 55 seconds
1 year ago
S1 E1 - J&J MedTech’s John Murray and Dr. Berenstein on the early evolution of neurovascular treatments
In this episode of Neuro Innovation Talks, the newest podcast series in the DeviceTalks Podcast Network, the DeviceTalks editors invite Johnson & Johnson MedTech Neurovascular's Head of Global Marketing, John Murray to take over the podcast studio and bring to light the stories from the pioneering neurointerventionalists who have helped shape the stroke industry.
In the first episode, Host John Murray sits down with Alejandro Berenstein, MD, Professor of Neurosurgery, Pediatrics and Radiology, Director of pediatric Cerebrovascular Surgery, Mount Sinai Health System, to discuss the incredible evolution of neurovascular surgery and its impact on modern healthcare. Dr. Berenstein shares his early inspirations, key breakthroughs, and the significant role mentors played in shaping his illustrious career. Highlighting landmark projects like the pioneering treatments for Vein of Galen Malformations (VOGM) and facial vascular anomalies, Dr. Berenstein shares the complexities and triumphs of his work.
His story provides a blueprint for aspiring medical professionals and innovators, demonstrating how personal experiences, visionary thinking, and collaborative efforts can lead to groundbreaking advancements that significantly impact patient outcomes.
Thank you to Zeus for sponsoring this episode of Neuro Innovation Talks. To learn more about how Zeus supports medical device companies, visit: www.zeusinc.com.
Special thanks to the following for their support in the development of this podcast: Joanna Colangelo, Johanna Fifi, Whitney Garrett, Howard Riina, Lillian Medina, and J. Mocco.
***
Enjoy this podcast? Follow Neuro Innovation Talks on all major podcast players: https://neuro-innovation-talks.castos.com/subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Neuro Innovation Talks: J&J MedTech Neurovascular
According to the CDC: Every three minutes and 11 seconds, someone dies of stroke. The medical device industry is answering the call in this country, developing new devices to help clear clots and speed patient recovery. Together with John Murray, Head of Global Strategic Marketing and Strategic Relationships at Johnson & Johnson MedTech Neurovascular, we'll talk with those pioneering neurosurgeons who are developing new procedures and setting higher expectations for new devices. We'll understand what drives them and learn how they view the future of this industry.
